These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 30067867)
21. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders. Gu Y; Estcourt LJ; Doree C; Hopewell S; Vyas P Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011577. PubMed ID: 26436602 [TBL] [Abstract][Full Text] [Related]
22. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Hambleton IR; Cho G Cochrane Database Syst Rev; 2016 May; (5):CD008360. PubMed ID: 27198469 [TBL] [Abstract][Full Text] [Related]
23. Transfusion of red blood cells stored for shorter versus longer duration for all conditions. Shah A; Brunskill SJ; Desborough MJ; Doree C; Trivella M; Stanworth SJ Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010801. PubMed ID: 30578732 [TBL] [Abstract][Full Text] [Related]
24. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Estcourt LJ; Hopewell S; Trivella M; Hambleton IR; Cho G Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684693 [TBL] [Abstract][Full Text] [Related]
25. Red blood cell transfusion for people undergoing hip fracture surgery. Brunskill SJ; Millette SL; Shokoohi A; Pulford EC; Doree C; Murphy MF; Stanworth S Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD009699. PubMed ID: 25897628 [TBL] [Abstract][Full Text] [Related]
26. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421 [TBL] [Abstract][Full Text] [Related]
27. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830 [TBL] [Abstract][Full Text] [Related]
28. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729 [TBL] [Abstract][Full Text] [Related]
29. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia. Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522 [TBL] [Abstract][Full Text] [Related]
30. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Carson JL; Stanworth SJ; Roubinian N; Fergusson DA; Triulzi D; Doree C; Hebert PC Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002042. PubMed ID: 27731885 [TBL] [Abstract][Full Text] [Related]
31. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery. Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892 [TBL] [Abstract][Full Text] [Related]
33. Big strokes in small persons. Adams RJ Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439 [TBL] [Abstract][Full Text] [Related]
34. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Estcourt LJ; Stanworth SJ; Doree C; Hopewell S; Trivella M; Murphy MF Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010983. PubMed ID: 26576687 [TBL] [Abstract][Full Text] [Related]
35. Pathogen-reduced platelets for the prevention of bleeding. Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627 [TBL] [Abstract][Full Text] [Related]
36. Folate supplementation in people with sickle cell disease. Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732 [TBL] [Abstract][Full Text] [Related]
37. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Crighton GL; Estcourt LJ; Wood EM; Trivella M; Doree C; Stanworth S Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010981. PubMed ID: 26422767 [TBL] [Abstract][Full Text] [Related]
38. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke. Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812 [TBL] [Abstract][Full Text] [Related]
39. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias. Foong WC; Loh CK; Ho JJ; Lau DS Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013767. PubMed ID: 36637054 [TBL] [Abstract][Full Text] [Related]